section name header

Basics

Description

According to the Joint National Committee's 2003 report, hypertension is defined as a systolic blood pressure (BP) >140 mm Hg or a diastolic BP >90 mm Hg.

Epidemiology

Incidence

  • Affects ~50 million people in the US (almost 25% of US adult population) and 1 billion people worldwide.
  • Individuals who are normotensive at age 55 years have a 90% lifetime risk of developing hypertension.

Prevalence

Increases with age. About half of all adults between the ages of 60 and 69 years and three quarters of all adults age >70 years have hypertension.

Morbidity

  • A linear relationship exists between an increase in BP and risk of developing ischemic heart disease and stroke.
  • Randomized controlled trials have provided unequivocal proof that lowering BP with regular medication dramatically reduces cardiovascular disability and death, and slows the progression of chronic kidney disease
  • Patients with isolated systolic hypertension also have a higher cardiovascular morbidity.
  • There is increasing evidence that patients with labile and white coat hypertension are also at increased risk of cardiac and vascular complications.

Mortality

Worldwide: ~7.5 million deaths annually are attributable to hypertension.

Etiology/Risk Factors
Physiology/Pathophysiology
Anesthetic GOALS/GUIDING Principles

Diagnosis

Symptoms

Usually asymptomatic

History

  • Preoperative increases in BP due to anxiety or white coat syndrome can be distinguished from previous clinic BP measurements.
  • A "silent killer." ~30% of adults are unaware of their hypertension and may present to the preoperative suite undiagnosed.
  • Questioning should be directed at determining the severity, presence of target organ damage, and associated comorbidities.

Signs/Physical Exam

  • Vital signs, peripheral pulses, body mass index (BMI)
  • Cardiac examination
  • Auscultation for carotid, abdominal, or renal bruits and assessment for abdominal or renal masses.
Treatment History

This may include adoption of healthy lifestyles that reduce, prevent or delay hypertension, and increase the efficacy of antihypertensive medications. Lifestyle modifications include adoption of dietary changes that are low in salt and rich in fruits and vegetables, limitation of alcohol intake, regular exercise, and weight loss.

Medications
Diagnostic Tests & Interpretation

Labs/Studies

  • Renal function: CBC, electrolytes, BUN, creatinine, glucose, urinary albumin
  • Cardiovascular function: Chest radiography, EKG, stress test or coronary angiography, as appropriate
  • Cerebrovascular function: Carotid artery duplex scan, as appropriate
CONCOMITANT ORGAN DYSFUNCTION
Circumstances to delay/Conditions
Classifications

Treatment

PREOPERATIVE PREPARATION

Premedications

  • In general, antihypertensive medications should be continued in the preoperative and postoperative period. An increased risk of intraoperative bradycardia has been associated with beta-blockers and intraoperative hypotension with calcium channel blockers, ACE inhibitors, and ARBs on the morning of surgery.
  • Anxiolytics such as midazolam are extremely useful to decrease the level of anxiety and consequent increases in BP prior to surgery.
INTRAOPERATIVE CARE

Choice of Anesthesia

  • Dependent on the type and site of surgery, associated comorbidities, patient's preference, etc.
  • Regional anesthesia may, however, obtund the sympathetic hypertensive response to surgical stimuli. Hypotension may occur with neuraxial blocks, especially in the presence of hypovolemia.

Monitors

  • Standard ASA monitors are adequate in most patients.
  • Invasive arterial line monitoring for continuous BP monitoring is indicated in patients with uncontrolled hypertension, certain comorbidities, or surgical procedures.
  • Other invasive hemodynamic monitoring may be indicated based upon comorbidities, surgical procedure.

Induction/Airway Management

  • Time of wide BP swings that can result in impaired myocardial oxygen supply or demand. Consider frequent cycling and anticipate and treat perturberances.
  • Choice of induction medication is less important than careful titration. Hypotension can result from sympatholytic and/or direct vasodilatory effects combined with intravascular volume depletion, and is commonly treated with a fast onset, short duration vasopressor.
  • Hypertensive stress responses to airway manipulation may be decreased with the prophylactic or therapeutic use of fentanyl, beta-blockers, or vasodilator drugs such as nitroglycerine.

Maintenance

  • None of the modern inhalational anesthetic agents have been shown to have any advantages over the other.
  • Hypertension is usually the result of light anesthesia, surgical stimulus, drug errors, hypoxia, hypercarbia, or fluid overload. Unusual causes of sudden, unexpected, or severe hypertension in the perioperative period include undiagnosed pheochromocytoma, hyperthyroidism, malignant hyperthermia, intracranial hypertension, or other causes mentioned above related to withdrawal of drugs like clonidine or interaction of MAO inhibitors with sympathomimetic agents.
  • Hypotension should be carefully avoided to maintain cerebral blood flow (CBF) as there is likely a right shift in the cerebral autoregulation curve. Common causes of intraoperative hypotension include hypovolemia, anesthetic drug overdose, or interaction with beta-blockers, calcium channel blocker, ACE Inhibitors, or ARBs.

Extubation/Emergence

Anticipate a hypertensive response and be prepared to treat.

Follow-Up

Bed Acuity

Uncontrolled hypertension requires a higher level of care and monitoring.

Medications/Lab Studies/Consults

Resume antihypertensive medications as soon as possible after surgery. If oral intake is not possible, the drug should be administered via the nasogastric tube or IV route (equivalent doses, preferably same class).

Complications

References

  1. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 Report. JAMA. 2003;21(289):25602572.
  2. Smith I , Jackson I. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: Should they be stopped or not before ambulatory anaesthesia?Curr Opin Anesthesiol. 2010;23:687690.

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Codes

ICD9

401.9 Unspecified essential hypertension

ICD10

I10 Essential (primary) hypertension

Clinical Pearls

Author(s)

Gundappa Neelakanta , MD